tirzepatide revive rx New compound dosing instructions from reviveRx algorx

- Kurt thought there was a 50% chance all GLP-1 compounding would end in the next 6 months (both 503A and 503B) - Did not mention direct communication from the FDA telling them to stop compounding GLP-1s - ProRx felt it was time to stop due to the end of the shortage in March 2025, and did not feel influenced by the April 1 FDA statement - Kurt thinks 503B production of GLP-1s are underreported and much larger than thought - 503As can't take care of the compounded GLP-1 market at their current capacity - We both have concerns about patient access without compounded GLP-1s and worry it will send more patients to the grey market for RUO injections that don't have the same level of sterility and regulation To view or add a comment, sign in Every year, innovators rush into GLP studies before they're truly ready

60+ deals Weight Loss in Monroe, NC 60+ Deals available CosmeticRX Semaglutide or Tirzepatide Weight Loss Program with Consultation 4.1(4,377) -80% 1stRX Semaglutide and Tirzepatide Weight Loss Programs with Consultation 4.1(80) -40% FancyMeds Semaglutide or Tirzepatide Weight Loss Program with Consultation 3.7(949) -72% LeanerRx Semaglutide or Tirzepatide Weight Management Program with Consultation 4.3(835) -60% Juiced

Another way to limit side effects is to increase the dose slowly over time

Those who stopped treatment altogether retained less than half

This trade-off exists whether using branded or compounded medications

Two groups were compared by KolmogorovSmirnov analysis, KruskalWallis and the MannWhitney U